Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Goetz

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic Chemistry|September 10, 2020
Development of activity-based probes for the protein deacylase Sirt1Christopher J Goetz, Daniel J Sprague, Brian C Smith
Molecules (Basel, Switzerland)|March 13, 2024
Current Trends in Sirtuin Activator and Inhibitor DevelopmentKarina L Bursch, Christopher J Goetz, Brian C Smith
The Journal of Biological Chemistry|February 12, 2025
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomainsMichael D Olp, Karina L Bursch, Sarah L Wynia-Smith, et al.
The Journal of Biological Chemistry|March 9, 2024
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppressionKarina L Bursch, Christopher J Goetz, Guanming Jiao, et al.
ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.
The Laryngoscope|June 9, 2022
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse ModelNikki Johnston, Tina L Samuels, Christopher J Goetz, et al.
Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic Chemistry|September 10, 2020
Development of activity-based probes for the protein deacylase Sirt1Christopher J Goetz, Daniel J Sprague, Brian C Smith
Molecules (Basel, Switzerland)|March 13, 2024
Current Trends in Sirtuin Activator and Inhibitor DevelopmentKarina L Bursch, Christopher J Goetz, Brian C Smith
The Journal of Biological Chemistry|February 12, 2025
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomainsMichael D Olp, Karina L Bursch, Sarah L Wynia-Smith, et al.
The Journal of Biological Chemistry|March 9, 2024
Cancer-associated polybromo-1 bromodomain 4 missense variants variably impact bromodomain ligand binding and cell growth suppressionKarina L Bursch, Christopher J Goetz, Guanming Jiao, et al.
ACS Chemical Biology|March 10, 2020
Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding SitesMichael D Olp, Daniel J Sprague, Christopher J Goetz, et al.
The Laryngoscope|June 9, 2022
Oral and Inhaled Fosamprenavir Reverses Pepsin-Induced Damage in a Laryngopharyngeal Reflux Mouse ModelNikki Johnston, Tina L Samuels, Christopher J Goetz, et al.
Journal of Medicinal Chemistry|October 13, 2022
Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment ScreeningShifali Shishodia, Raymundo Nuñez, Brayden P Strohmier, et al.
Pageof 1